MARKET

DXR

DXR

DAXOR CORP
AMEX

Real-time Quotes | Nasdaq Last Sale

11.41
-0.05
-0.42%
Closed 16:00 03/05 EST
OPEN
11.69
PREV CLOSE
11.46
HIGH
11.94
LOW
11.41
VOLUME
11.59K
TURNOVER
--
52 WEEK HIGH
24.08
52 WEEK LOW
8.47
MARKET CAP
44.37M
P/E (TTM)
-25.3668
1D
5D
1M
3M
1Y
5Y
Daxor to Present at the H.C. Wainwright Global Life Sciences Conference
GlobeNewswire · 2d ago
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)
Does the February share price for Daxor Corporation ( NYSEMKT:DXR ) reflect what it's really worth? Today, we will...
Simply Wall St. · 02/27 07:39
Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) The global leader in blood volume technology today filed its Annual Report to Shareholders on Form N-CSR, disclosing its schedule...
GlobeNewswire · 02/26 13:30
Daxor Corporation Says Receives ISO 13485 Quality Management System Certification For Blood Volume Analyzer BVA-100
DAXOR CORPORATION RECEIVES ISO 13485 QUALITY MANAGEMENT SYSTEM CERTIFICATION FOR THE BLOOD VOLUME ANALYZER (BVA-100®) Important Milestone for International Distribution NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) --
Benzinga · 02/19 13:34
DAXOR CORPORATION RECEIVES ISO 13485 QUALITY MANAGEMENT SYSTEM CERTIFICATION FOR THE BLOOD VOLUME ANALYZER (BVA-100(R))
NEW YORK, Feb 19, 2021 (GLOBE NEWSWIRE via COMTEX) -- Important Milestone for International Distribution NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Daxor...
GlobeNewswire · 02/19 13:30
Maxim Group Maintains a Buy Rating on Daxor (DXR)
Maxim Group analyst Jason McCarthy maintained a Buy rating on Daxor (DXR) on March 26 and set a price target of $22.00. The company's shares closed last
SmarterAnalyst · 02/09 09:10
Daxor Corp Says Awarded Grant From Center For Advancing Point Of Care Technologies To Develop A Point-Of-Care Blood Volume Analyzer
DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation
Benzinga · 02/05 13:34
DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER
GlobeNewswire · 02/05 13:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DXR. Analyze the recent business situations of DAXOR CORP through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DXR stock price target is 22.00 with a high estimate of 22.00 and a low estimate of 22.00.
EPS
Institutional Holdings
Institutions: 4
Institutional Holdings: 79.82K
% Owned: 2.05%
Shares Outstanding: 3.89M
TypeInstitutionsShares
Increased
3
6.30K
New
0
0
Decreased
1
2.00K
Sold Out
3
74.58K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Feldschuh
Chief Financial Officer
Robert Michel
Chief Scientific Officer/Director
Jonathan Feldschuh
Director
Henry Cremisi
Director
Edward Feuer
Independent Director
Joy Goudie
Independent Director
James Lombard
Independent Director
Robert Willens
Declaration Date
Dividend Per Share
Ex-Div Date
12/28/2017
Dividend USD 0.03
01/05/2018
11/18/2016
Dividend USD 0.03
12/20/2016
12/09/2015
Dividend USD 0.04
12/18/2015
11/17/2014
Dividend USD 0.03
12/04/2014
11/15/2013
Dividend USD 0.05
12/05/2013
11/29/2012
Dividend USD 0.1
12/07/2012
08/03/2012
Dividend USD 0.1
08/10/2012
11/08/2011
Dividend USD 0.1
11/16/2011
05/25/2011
Dividend USD 0.15
05/27/2011
11/30/2010
Dividend USD 0.65
12/14/2010
09/02/2010
Dividend USD 0.25
09/13/2010
05/11/2010
Dividend USD 0.1
05/27/2010
--
Dividend USD 1
12/08/2009
--
Dividend USD 0.25
08/21/2009
--
Dividend USD 0.1
05/27/2009
--
Dividend USD 1
12/10/2008
--
Dividend USD 0.25
10/31/2008
--
Dividend USD 0.25
07/24/2008
About DXR
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions.

Webull offers kinds of Daxor Corporation stock information, including AMEX:DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.